drugset / Trial / NCT00155350

Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients

NCT00155350

Phase 4 Unknown 120 enrolled National Taiwan University Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

In this study, we, the investigators at National Taiwan University Hospital, will evaluate the efficacy of pharmacological therapy targeted to reduce insulin resistance (pioglitazone) on the progression and compositional change of non-obstructive coronary atherosclerotic plaques and coronary calcification by serial intravascular ultrasound (IVUS)/multi-detector-row computed tomography (MDCT) follow-up in patients with type 2 diabetes or non-diabetic metabolic syndrome during a 2-year period.

Timeline

Start
2004-11
Primary completion
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Pioglitazone Small molecule 30 mg